{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:12:47Z","timestamp":1758845567912,"version":"3.44.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,25]]},"DOI":"10.7759\/cureus.93167","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:20:31Z","timestamp":1758792031000},"source":"Crossref","is-referenced-by-count":0,"title":["Extensively Drug-Resistant Tuberculosis With Treatment-Limiting Mood Disorder: A Case of Complex Regimen Selection and Mental Health Challenges"],"prefix":"10.7759","author":[{"given":"Sahak","family":"Mkrtchyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Tuberculosis resurges as top infectious disease killer. (2024). Accessed. August 1, 2025: https:\/\/www.who.int\/news\/item\/29-10-2024-tuberculosis-resurges-as-top-infectious-disease-killer."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07961-8","article-title":"Epidemiology of TB in prisoners: a metanalysis of the prevalence of active and latent TB","volume":"23","author":"Placeres AF","year":"2023","unstructured":"Placeres AF, de Almeida Soares D, Delpino FM, et al.. Epidemiology of TB in prisoners: a metanalysis of the prevalence of active and latent TB. BMC Infect Dis. 2023, 23:20. 10.1186\/s12879-022-07961-8","journal-title":"BMC Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.855515","article-title":"Mental health status and its impact on TB treatment and its outcomes: a scoping literature review","volume":"10","author":"Agbeko CK","year":"2022","unstructured":"Agbeko CK, Mallah MA, He B, Liu Q, Song H, Wang J. Mental health status and its impact on TB treatment and its outcomes: a scoping literature review. Front Public Health. 2022, 10:855515. 10.3389\/fpubh.2022.855515","journal-title":"Front Public Health"},{"key":"ref4","unstructured":"Tuberculosis. extensively drug-resistant tuberculosis (XDR-TB). (2024). Accessed: August 2, 2025: https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/tuberculosis-extensively-drug-resistant-tuberculosis-(XDR-TB)."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2023.06.014","article-title":"Global treatment outcomes of extensively drug-resistant tuberculosis in adults: a systematic review and meta-analysis","volume":"87","author":"Pedersen OS","year":"2023","unstructured":"Pedersen OS, Holmgaard FB, Mikkelsen MK, et al.. Global treatment outcomes of extensively drug-resistant tuberculosis in adults: a systematic review and meta-analysis. J Infect. 2023, 87:177-89. 10.1016\/j.jinf.2023.06.014","journal-title":"J Infect"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.77078","article-title":"Cycloserine-induced psychosis: a case report","volume":"17","author":"Raikar SR","year":"2025","unstructured":"Raikar SR, G S, Sneha S, Rajkumar J. Cycloserine-induced psychosis: a case report. Cureus. 2025, 17:e77078. 10.7759\/cureus.77078","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ph16081105","article-title":"Depressive and other adverse CNS effects of fluoroquinolones","volume":"16","author":"Wierzbi\u0144ski P","year":"2023","unstructured":"Wierzbi\u0144ski P, Hubska J, Henzler M, Kucharski B, Bie\u015b R, Krzystanek M. Depressive and other adverse CNS effects of fluoroquinolones. Pharmaceuticals (Basel). 2023, 16:1105. 10.3390\/ph16081105","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002884","article-title":"The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials","volume":"16","author":"Vernon A","year":"2019","unstructured":"Vernon A, Fielding K, Savic R, Dodd L, Nahid P. The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials. PLoS Med. 2019, 16:e1002884. 10.1371\/journal.pmed.1002884","journal-title":"PLoS Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S369715","article-title":"High incidence of psychiatric disorders associated with cycloserine treatment of multidrug-resistant tuberculosis patients: a cohort study in Beijing, China","volume":"15","author":"Pang Y","year":"2022","unstructured":"Pang Y, Liu R, Song Y, et al.. High incidence of psychiatric disorders associated with cycloserine treatment of multidrug-resistant tuberculosis patients: a cohort study in Beijing, China. Infect Drug Resist. 2022, 15:3725-32. 10.2147\/IDR.S369715","journal-title":"Infect Drug Resist"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-81","article-title":"The impact of diabetes on tuberculosis treatment outcomes: a systematic review","volume":"9","author":"Baker MA","year":"2011","unstructured":"Baker MA, Harries AD, Jeon CY, et al.. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011, 9:81. 10.1186\/1741-7015-9-81","journal-title":"BMC Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy7030110","article-title":"Overview and insights into carbapenem allergy","volume":"7","author":"Lee Y","year":"2019","unstructured":"Lee Y, Bradley N. Overview and insights into carbapenem allergy. Pharmacy (Basel). 2019, 7:110. 10.3390\/pharmacy7030110","journal-title":"Pharmacy (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2014.35.3791","article-title":"Prevalence and characteristics of reported penicillin allergy in an urban outpatient adult population","volume":"35","author":"Albin S","year":"2014","unstructured":"Albin S, Agarwal S. Prevalence and characteristics of reported penicillin allergy in an urban outpatient adult population. Allergy Asthma Proc. 2014, 35:489-94. 10.2500\/aap.2014.35.3791","journal-title":"Allergy Asthma Proc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/406435-extensively-drug-resistant-tuberculosis-with-treatment-limiting-mood-disorder-a-case-of-complex-regimen-selection-and-mental-health-challenges","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:20:35Z","timestamp":1758792035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/406435-extensively-drug-resistant-tuberculosis-with-treatment-limiting-mood-disorder-a-case-of-complex-regimen-selection-and-mental-health-challenges"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.93167","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,25]]}}}